Phase 3 Breast Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are a woman aged 18 or older
• You have been diagnosed with HER2-positive breast cancer, confirmed through a laboratory test on a tissue sample
• You are expected to receive a treatment plan that includes a drug called pyrotinib, either before surgery or for breast cancer that has spread or cannot be removed
• You have received no more than one previous HER2-targeted treatment for cancer that has come back or spread
• You are able to use a mobile phone and read on your own
• The trial doctor has assessed that you are in a suitable mental and physical condition to take part

Who may not be able to join:

• You have a history of cognitive impairment (problems with memory or thinking)
• You have severe problems with your vision or hearing
• You have taken pyrotinib before
• You are pregnant, breastfeeding, or planning to become pregnant
• You have tried a talking-based therapy (such as cognitive-behavioral therapy) in the past year that did not help (confirm with trial site)
• You have taken part in another clinical trial in the month before being assessed for this study
• The trial doctor has decided that your mental or physical condition makes participation unsuitable

Important: Always verify eligibility with the trial site directly before applying.